Long non-coding RNAs (lncRNAs), which are RNA transcripts exceeding 200 nucleotides
were believed to lack any protein-coding capacity. But advancements in-omics technology …

The genomic era has brought about a transformative shift in our comprehension of cancer,
unveiling the intricate molecular landscape underlying disease development. Eye cancers …

Long noncoding RNAs (lncRNAs) possess the potential for therapeutic targeting to treat
many disorders, including cancers. Several RNA-based therapeutics (ASOs and small …

The inhibition of mammalian target of rapamycin (mTOR) with rapamycin (RAPA) provides
protection against myocardial ischemia/reperfusion (I/R) injury in diabetes. Since …

Abstract Background Tumor-associated macrophages (TAMs) significantly influence the
progression, metastasis, and recurrence of esophageal squamous cell carcinoma (ESCC) …

During the past few years, unexpected developments have driven studies in the field of
clinical immunology. One driver of immense impact was the outbreak of a pandemic caused …

Myocardial cell fate specification takes place during the early stages of heart development
as the precardiac mesoderm is configured into two symmetrical sets of bilateral precursor …

Cardiometabolic diseases (CMDs) are interrelated and multifactorial conditions, including
arterial hypertension, type 2 diabetes, heart failure, coronary artery disease, and stroke. Due …

The purpose of this work is to comprehensively understand the adaptive response of
multiple epigenetic modifications on gene expression changes driven by exercise. Here, we …

长链非编码RNA H19促进血管钙化：基于抑制Bax抑制因子1/视神经萎缩蛋白1通路- PMC Back to
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …